临床不确定性帕金森综合征的黑质纹状体成像:SPECT、PET与MRI头对头比较
研究在35例转诊行DAT成像的患者中头对头比较[123I]FP-CIT SPECT、[18F]FE-PE2I PET与黑质MRI。18例诊断为神经退行性帕金森综合征,SPECT与PET的DAT可用性完全一致、强相关且诊断性能同样优秀;黑质神经黑色素减少提供中等诊断准确性,中脑铁含量无诊断信息。结论认为早期帕金森综合征中DAT神经成像(SPECT与PET)诊断价值相当且优于黑质MRI。
要点
- SPECT与PET的DAT可用性完全一致且强相关,诊断性能同样优秀。
- 黑质神经黑色素减少提供中等诊断准确性,并提示随病程降低。
- 中脑铁含量组间无差异且无诊断信息。
核心结论
- 早期帕金森综合征中,DAT神经成像SPECT与PET提供相当且优于黑质MRI的诊断价值。
研究设计与样本
- 在35例转诊行诊断性DAT成像的患者中头对头比较[123I]FP-CIT SPECT、[18F]FE-PE2I PET与黑质MRI。
- 黑质MRI采用神经黑色素敏感梯度回波磁化传递对比MRI和铁敏感STAGE MRI。
- 通过问卷记录患者对SPECT与PET的满意度。
主要发现
- 18例诊断为神经退行性帕金森综合征,中位症状持续时间29个月。
- SPECT与PET测得的DAT可用性在所有病例中完全一致、强相关且诊断性能同样优秀。
- 患者问卷条目在两种模态间无差异或偏向SPECT。
- 神经退行性帕金森综合征患者黑质神经黑色素含量降低,提供中等诊断准确性,并有随病程降低的迹象。
- 中脑铁含量组间无差异且未提供诊断信息。
临床怎么用
- 在早期帕金森综合征的DAT成像中,SPECT与PET诊断价值相当,可依据可及性选择。
- 黑质MRI(神经黑色素与铁成像)不宜替代DAT神经成像用于诊断。
局限性
- 样本量35例,其中18例诊断为神经退行性帕金森综合征。
- 中位症状持续时间为29个月,结论主要适用于早期阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neurodegenerative parkinsonism is characterized by degeneration of the dopaminergic nigrostriatal pathways and a reduction in nigral neuromelanin. Dopamine transporter (DAT) imaging assesses presynaptic striatal dopaminergic function and is typically performed with [123I]FP-CIT SPECT-CT, but has recently also become available with [18F]FE-PE2I PET-CT. Magnetic resonance imaging (MRI) can explore disease-related changes by quantifying neuromelanin and iron deposition associated with the loss of nigral neurons. METHODS: In this study, we conducted a head-to-head comparison of [¹²³I]FP-CIT SPECT, [¹⁸F]FE-PE2I PET, and nigral MRI in 35 patients referred for diagnostic DAT imaging. Nigral MRI was performed with neuromelanin-sensitive gradient echo magnetization-transfer contrast MRI and iron-sensitive STrategically Acquired Gradient Echo (STAGE) MRI. Patient satisfaction with SPECT and PET was recorded via questionnaires. RESULTS: Eighteen patients were diagnosed with neurodegenerative parkinsonism with a median symptom duration of 29 months. DAT availability as measured with SPECT and PET showed complete concordance across cases, correlated strongly, and demonstrated equally excellent diagnostic performance. Patient questionnaire items were either not different between modalities or in favor of SPECT. Nigral neuromelanin content was reduced in patients with neurodegenerative parkinsonism and provided intermediate diagnostic accuracy, with indications of lower neuromelanin with disease duration. Midbrain iron content did not differ between groups and provided no diagnostic information. CONCLUSION: Our findings indicate that in early-stage parkinsonism, DAT neuroimaging with SPECT and PET provides comparable and superior diagnostic value relative to nigral MRI.
引用
- Thomsen G, Brendstrup-Brix K, Svarer C, et al. Nigrostriatal imaging in patients with clinically uncertain Parkinsonian syndromes: a head-to-head comparison between SPECT, PET, and MRI. Eur J Nucl Med Mol Imaging. 2026. PMID: 42752958. doi:10.1007/s00259-026-08184-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。